Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-28T14:25:33.725Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (OCTOBER 2007)

Published online by Cambridge University Press:  01 January 2008

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 11 , Issue 1 , January 2008 , e1
Copyright
Copyright © Cambridge University Press 2007

References

1.Cao, YX, Luo, JL, Karin, M. IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proc Natl Acad Sci USA 2007; 104: 15852–15857.CrossRefGoogle ScholarPubMed
2.Charafe-Jauffret, E, Monville, F, Bertucci, F, Esterni, B, Ginestier, C, Finetti, P, Cervera, N, Geneix, J, Hassanein, M, Rabayrol, L, Sobol, H, Taranger-Charpin, C, Xerri, L, Viens, P, Birnbaum, D, Jacquemier, J. Moesin expression is a marker of basal breast carcinomas. Int J Cancer 2007; 121: 1779–1785.CrossRefGoogle ScholarPubMed
3.Cheng, JW, Yu, DV, Zhou, JH, Shapiro, DJ. Tamoxifen induction of CCAAT enhancer-binding protein α is required for tamoxifen-induced apoptosis. J Biol Chem 2007; 282: 30535–30543.CrossRefGoogle ScholarPubMed
4.Degen, M, Brellier, F, Kain, R, Ruiz, C, Terracciano, L, Orend, G, Chiquet-Ehrismann, R. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. Cancer Res 2007; 67: 9169–9179.CrossRefGoogle ScholarPubMed
5.Durocher, F, Labrie, Y, Ouellette, G, Simard, J. Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer. J Hum Genet 2007; 52: 963–977.CrossRefGoogle ScholarPubMed
6.Emlet, DR, Brown, KA, Kociban, DL, Pollice, AA, Smith, CA, Ong, BBL, Shackney, SE. Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines. Mol Cancer Ther 2007; 6: 2664–2674.CrossRefGoogle ScholarPubMed
7.Jakobsen, CG, Rasmussen, N, Laenkholm, AV, Ditzel, HJ. Phage display-derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78. Cancer Res 2007; 67: 9507–9517.CrossRefGoogle Scholar
8.John, EM, Schwartz, GG, Koo, J, Wang, W, Ingles, SA. Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Breast Cancer Risk in a Multiethnic Population. Am J Epidemiol 2007; 166: 1409–1419.CrossRefGoogle Scholar
9.Karnoub, AE, Dash, AB, Vo, AP, Sullivan, A, Brooks, MW, Bell, GW, Richardson, AL, Polyak, K, Tubo, R, Weinberg, RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557–563.CrossRefGoogle ScholarPubMed
10. Khaleque MA, Bharti A, Gong J, Gray PJ, Sachdev V, Ciocca DR, Stati A, Fanelli M, Calderwood SK. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene 2007; 10.1038/sj.onc.1210834.CrossRefGoogle Scholar
11. Kim SJ, Nakayama S, Miyoshi Y, Taguchi T, Tamaki Y, Matsushima T, Torikoshi Y, Tanaka S, Yoshida T, Ishihara H, Noguchi S. Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer. Ann Oncol 2007; 10.1093/annonc/mdm358.CrossRefGoogle Scholar
12. Kotzsch M, Sieuwerts A, Grosser M, Meye A, Fuessel S, Meijer-van Gelder M, Smid M, Schmitt M, Baretton G, Luther T, Magdolen V, Foekens J. Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor. Breast Cancer Res Treat 2007; 10.1007/s10549-007-9782-6.CrossRefGoogle Scholar
13.Lauber, SN, Gooderharn, NJ. The cooked meat-derived genotoxic carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine has potent hormone-like activity: Mechanistic support for a role in breast cancer. Cancer Res 2007; 67: 9597–9602.CrossRefGoogle ScholarPubMed
14. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G, Burkman RT, Folger SG, Norman S, McDonald JA, Spirtas R. Timing of Menarche and First Full-Term Birth in Relation to Breast Cancer Risk. Am J Epidemiol 2007; 10.1093/aje/kwm271.CrossRefGoogle Scholar
15.Lu, DM, Sivaprasad, U, Huang, J, Shankar, E, Morrow, S, Basu, A. Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation. Apoptosis 2007; 12: 1893–1900.CrossRefGoogle ScholarPubMed
16.Ma, L, Teruya-Feldstein, J, Weinberg, RA. Tumour invasion and metastasis initiated by microRNA 10b in breast cancer. Nature 2007; 449: 682–688.CrossRefGoogle ScholarPubMed
17.Menendez, JA, Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763–777.CrossRefGoogle ScholarPubMed
18.Migliaccio, A, Varricchio, L, De Falco, A, Castoria, G, Arra, C, Yamaguchi, H, Ciociola, A, Lombardi, M, Di Stasio, R, Barbieri, A, Baldi, A, Barone, MV, Appella, E, Auricchio, F. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth. Oncogene 2007; 26: 6619–6629.CrossRefGoogle Scholar
19.Miller, WR, Larionov, AA, Renshaw, L, Anderson, TJ, White, S, Murray, J, Murray, E, Hampton, G, Walker, JR, Ho, S, Krause, A, Evans, DB, Dixon, JM. Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. Pharmacogenetics Genomics 2007; 17: 813–826.CrossRefGoogle ScholarPubMed
20. Millikan R, Newman B, Tse C, Moorman P, Conway K, Dressler L, Smith L, Labbok M, Geradts J, Bensen J, Jackson S, Nyante S, Livasy C, Carey L, Earp H, Perou C. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2007; 10.1007/s10549-007-9790-6.CrossRefGoogle Scholar
21.Pu, J, McCaig, CD, Cao, L, Zhao, ZQ, Segall, JE, Zhao, M. EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells. J Cell Sci 2007; 120: 3395–3403.CrossRefGoogle ScholarPubMed
22.Pujana, MA, Han, LM, Starita, KN, Stevens, KN, Tewari, M, Ahn, JS, Rennert, G, Moreno, V, Kirchhoff, T, Gold, B, Assmann, V, ElShamy, WM, Rual, JF, Levine, D, Rozek, LS, Gelman, RS, Gunsalus, KC, Greenberg, RA, Sobhian, B, Bertin, N, Venkatesan, K, Ayivi-Guedehoussou, N, Sole, X, Hernandez, P, Lazaro, C, Nathanson, KL, Weber, BL, Cusick, ME, Hill, DE, Offit, K, Livingston, DM, Gruber, SB, Parvin, JD, Vidal, M. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007; 39: 1338–1349.CrossRefGoogle ScholarPubMed
23.Roberts, CG, Gurisik, E, Biden, TJ, Sutherland, RL, Butt, AJ. Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism. Mol Cancer Ther 2007; 6: 2777–2785.CrossRefGoogle ScholarPubMed
24.Schmidt, MK, Reincke, S, Broeks, A, Braaf, LM, Hogervorst, FBL, Tollenaar, R, Johnson, N, Fletcher, O, Peto, J, Tommiska, J, Blomqvist, C, Nevanlinna, HA, Healey, CS, Dunning, AM, Pharoah, PDP, Easton, DF, Doork, T, Van’t Veer, LJ. Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. Cancer Res 2007; 67: 9584–9590.CrossRefGoogle ScholarPubMed
25. Tan D, Marchio C, Jones R, Savage K, Smith I, Dowsett M, Reis-Filho J. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat 2007; 10.1007/s10549-007-9756-8.CrossRefGoogle Scholar
26.Wittmann, BM, Sherk, A, McDonnell, DP. Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators. Cancer Res 2007; 67: 9549–9560.CrossRefGoogle ScholarPubMed
27.Wolf, I, Bose, S, Desmond, JC, Lin, BT, Williamson, EA, Karlan, BY, Koeffler, HP. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treat 2007; 105: 139–155.CrossRefGoogle ScholarPubMed
28.Wood, LD, Parsons, DW, Jones, S, Lin, J, Sjoeblom, T, Leary, RJ, Shen, D, Boca, SM, Barber, T, Ptak, J, Silliman, N, Szabo, S, Dezso, Z, Ustyanksky, V, Nikolskaya, T, Nikolsky, Y, Karchin, R, Wilson, PA, Kaminker, JS, Zhang, Z, Croshaw, R, Willis, J, Dawson, D, Shipitsin, M, Willson, JKV, Sukumar, S, Polyak, K, Park, BH, Pethiyagoda, CL, Pant, PVK, Ballinger, DG, Sparks, AB, Hartigan, J, Smith, DR, Suh, E, Papadopoulos, N, Buckhaults, P, Markowitz, SD, Parmigiani, G, Kinzler, KW, Velculescu, VE, Vogelstein, B. The Genomic Landscapes of Human Breast and Colorectal Cancers. Science 2007; 318: 1108–1113.CrossRefGoogle ScholarPubMed
29.Zheng, Y, Zhou, H, Modzelewski, JRK, Kalak, R, Blair, JM, Seibel, MJ, Dunstan, CR. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res 2007; 67: 9542–9548.CrossRefGoogle ScholarPubMed
30.Zhou, JB, Wulfkuhle, J, Zhang, H, Gu, PH, Yang, YQ, Deng, JH, Margolick, JB, Liotta, LA, Petricoin, E, Zhang, Y. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 2007; 104: 16158–16163.CrossRefGoogle ScholarPubMed